4.0 Article

Modelling the test, trace and quarantine strategy to control the COVID-19 epidemic in the state of Sao Paulo, Brazil

期刊

INFECTIOUS DISEASE MODELLING
卷 6, 期 -, 页码 46-55

出版社

KEAI PUBLISHING LTD
DOI: 10.1016/j.idm.2020.11.004

关键词

COVID-19; SARS-CoV-2; Testing; Cost-analysis; Modelling

资金

  1. project ZikaPLAN - European Union's Horizon 2020 research and innovation programme [734584]
  2. CNPq
  3. FAPES
  4. Fundacao Butantan
  5. H2020 Societal Challenges Programme [734584] Funding Source: H2020 Societal Challenges Programme

向作者/读者索取更多资源

The state of Sao Paulo in Brazil relied heavily on massive testing strategy to control COVID-19 outbreak due to ineffective social distancing measures. Simulation studies suggest that testing only symptomatic cases and their immediate contacts can reduce 90% of total cases at a smaller cost.
Testing for detecting the infection by SARS-CoV-2 is the bridge between the lockdown and the opening of society. In this paper we modelled and simulated a test-trace-and-quarantine strategy to control the COVID-19 outbreak in the State of Sao Paulo, Brasil. The State of Sao Paulo failed to adopt an effective social distancing strategy, reaching at most 59% in late March and started to relax the measures in late June, dropping to 41% in 08 August. Therefore, Sao Paulo relies heavily on a massive testing strategy in the attempt to control the epidemic. Two alternative strategies combined with economic evaluations were simulated. One strategy included indiscriminately testing the entire population of the State, reaching more than 40 million people at a maximum cost of 2.25 billion USD, that would reduce the total number of cases by the end of 2020 by 90%. The second strategy investigated testing only symptomatic cases and their immediate contacts - this strategy reached a maximum cost of 150 million USD but also reduced the number of cases by 90%. The conclusion is that if the State of Sao Paulo had decided to adopt the simulated strategy on April the 1st, it would have been possible to reduce the total number of cases by 90% at a cost of 2.25 billion US dollars for the indiscriminate strategy but at a much smaller cost of 125 million US dollars for the selective testing of symptomatic cases and their contacts. (c) 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据